• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

姜黄素作为电子转移介体将 II 型光敏剂转化为 I 型光敏剂。

Thymoquinone as an electron transfer mediator to convert Type II photosensitizers to Type I photosensitizers.

机构信息

Joint School of National University of Singapore and Tianjin University, International Campus of Tianjin University, Binhai New City, Fuzhou, China.

Department of Chemical and Biomolecular Engineering, National University of Singapore, Singapore, Singapore.

出版信息

Nat Commun. 2024 Jun 10;15(1):4943. doi: 10.1038/s41467-024-49311-z.

DOI:10.1038/s41467-024-49311-z
PMID:38858372
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11164902/
Abstract

The development of Type I photosensitizers (PSs) is of great importance due to the inherent hypoxic intolerance of photodynamic therapy (PDT) in the hypoxic microenvironment. Compared to Type II PSs, Type I PSs are less reported due to the absence of a general molecular design strategy. Herein, we report that the combination of typical Type II PS and natural substrate carvacrol (CA) can significantly facilitate the Type I pathway to efficiently generate superoxide radical (O). Detailed mechanism study suggests that CA is activated into thymoquinone (TQ) by local singlet oxygen generated from the PS upon light irradiation. With TQ as an efficient electron transfer mediator, it promotes the conversion of O to O by PS via electron transfer-based Type I pathway. Notably, three classical Type II PSs are employed to demonstrate the universality of the proposed approach. The Type I PDT against S. aureus has been demonstrated under hypoxic conditions in vitro. Furthermore, this coupled photodynamic agent exhibits significant bactericidal activity with an antibacterial rate of 99.6% for the bacterial-infection female mice in the in vivo experiments. Here, we show a simple, effective, and universal method to endow traditional Type II PSs with hypoxic tolerance.

摘要

由于光动力疗法(PDT)在缺氧微环境中固有的缺氧不耐受性,开发 I 型光敏剂(PS)非常重要。与 II 型 PS 相比,由于缺乏通用的分子设计策略,I 型 PS 的报道较少。本文报道了将典型的 II 型 PS 和天然底物香芹酚(CA)结合,可以显著促进 I 型途径,有效地生成超氧自由基(O)。详细的机制研究表明,CA 在光照下由 PS 产生的局部单线态氧激活为百里香醌(TQ)。TQ 作为有效的电子转移介体,通过基于电子转移的 I 型途径促进 PS 将 O 转化为 O。值得注意的是,三种经典的 II 型 PS 被用于证明所提出方法的普遍性。在体外缺氧条件下已经证明了针对金黄色葡萄球菌的 I 型 PDT。此外,这种偶联的光动力试剂在体内实验中对感染细菌的雌性小鼠表现出显著的杀菌活性,抗菌率达到 99.6%。在这里,我们展示了一种简单、有效、通用的方法,使传统的 II 型 PS 具有缺氧耐受性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/853a/11164902/3af63088a893/41467_2024_49311_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/853a/11164902/e4826d2815bd/41467_2024_49311_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/853a/11164902/4f0e293e2252/41467_2024_49311_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/853a/11164902/3d4cad00ef90/41467_2024_49311_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/853a/11164902/e13434064c2c/41467_2024_49311_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/853a/11164902/5eddca7af6a9/41467_2024_49311_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/853a/11164902/3af63088a893/41467_2024_49311_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/853a/11164902/e4826d2815bd/41467_2024_49311_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/853a/11164902/4f0e293e2252/41467_2024_49311_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/853a/11164902/3d4cad00ef90/41467_2024_49311_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/853a/11164902/e13434064c2c/41467_2024_49311_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/853a/11164902/5eddca7af6a9/41467_2024_49311_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/853a/11164902/3af63088a893/41467_2024_49311_Fig6_HTML.jpg

相似文献

1
Thymoquinone as an electron transfer mediator to convert Type II photosensitizers to Type I photosensitizers.姜黄素作为电子转移介体将 II 型光敏剂转化为 I 型光敏剂。
Nat Commun. 2024 Jun 10;15(1):4943. doi: 10.1038/s41467-024-49311-z.
2
Constructing Heavy-Atom-Free Photosensitizers for Hypoxic Tumor Phototherapy Based on Donor-Excited Photoinduced Electron-Transfer-Driven Type-I and Type-II Mechanisms.基于给体激子型光诱导电子转移驱动的 I 型和 II 型机制构建乏重原子光动力治疗剂用于缺氧肿瘤治疗。
ACS Appl Mater Interfaces. 2024 Aug 7;16(31):40428-40443. doi: 10.1021/acsami.4c02175. Epub 2024 Jul 23.
3
BODIPY-Based Photodynamic Agents for Exclusively Generating Superoxide Radical over Singlet Oxygen.基于 BODIPY 的光动力试剂,可专门产生超氧自由基而非单线态氧。
Angew Chem Int Ed Engl. 2021 Sep 1;60(36):19912-19920. doi: 10.1002/anie.202106748. Epub 2021 Aug 3.
4
High antimicrobial photodynamic activity of photosensitizer encapsulated dual-functional metallocatanionic vesicles against drug-resistant bacteria S. aureus.光敏剂封装的双功能金属catanionic 囊泡对耐甲氧西林金黄色葡萄球菌的高抗菌光动力活性。
Biomater Sci. 2020 May 21;8(10):2905-2920. doi: 10.1039/d0bm00323a. Epub 2020 Apr 20.
5
Insight into the efficiency of microalgae' lipidic extracts as photosensitizers for Antimicrobial Photodynamic Therapy against Staphylococcus aureus.洞察微藻脂质提取物作为光动力抗菌疗法治疗金黄色葡萄球菌的光敏剂的效率。
J Photochem Photobiol B. 2024 Oct;259:112997. doi: 10.1016/j.jphotobiol.2024.112997. Epub 2024 Aug 8.
6
Amplifying Free Radical Generation of AIE Photosensitizer with Small Singlet-Triplet Splitting for Hypoxia-Overcoming Photodynamic Therapy.通过小单重态-三重态分裂增强 AIE 光敏剂的自由基生成以克服缺氧的光动力治疗。
ACS Appl Mater Interfaces. 2022 Feb 2;14(4):5112-5121. doi: 10.1021/acsami.1c23797. Epub 2022 Jan 20.
7
Photodynamic inactivation of Staphylococcus aureus and methicillin-resistant Staphylococcus aureus with Ru(II)-based type I/type II photosensitizers.基于 Ru(II)的 I/II 型光敏剂对金黄色葡萄球菌和耐甲氧西林金黄色葡萄球菌的光动力灭活作用。
Photodiagnosis Photodyn Ther. 2013 Dec;10(4):615-25. doi: 10.1016/j.pdpdt.2013.07.001. Epub 2013 Aug 5.
8
Supramolecular photodynamic agents for simultaneous oxidation of NADH and generation of superoxide radical.用于同时氧化 NADH 和生成超氧自由基的超分子光动力剂。
Nat Commun. 2022 Oct 19;13(1):6179. doi: 10.1038/s41467-022-33924-3.
9
A design strategy of pure Type-I thiadiazolo[3,4-g]quinoxaline-based photosensitizers for photodynamic therapy.一种基于纯 I 型噻二唑并[3,4-g]喹喔啉的光动力治疗光敏剂的设计策略。
Eur J Med Chem. 2024 Feb 5;265:116059. doi: 10.1016/j.ejmech.2023.116059. Epub 2023 Dec 14.
10
Recent advances in type I organic photosensitizers for efficient photodynamic therapy for overcoming tumor hypoxia.近年来,I 型有机光敏剂在克服肿瘤缺氧的高效光动力治疗方面取得了进展。
J Mater Chem B. 2023 May 31;11(21):4600-4618. doi: 10.1039/d3tb00545c.

引用本文的文献

1
A Bromobenzoyl Pyridine Photosensitizer with Suppressed Phosphorescence for Efficient ROS-Based Photodynamic Therapy.一种具有抑制磷光的溴苯甲酰基吡啶光敏剂用于基于活性氧的高效光动力疗法。
J Fluoresc. 2025 Jul 5. doi: 10.1007/s10895-025-04427-3.
2
NRF2 modulates WNT signaling pathway to enhance photodynamic therapy resistance in oral leukoplakia.核因子E2相关因子2(NRF2)调节WNT信号通路以增强口腔白斑对光动力疗法的抗性。
EMBO Mol Med. 2025 Jun 10. doi: 10.1038/s44321-025-00256-w.
3
Endoplasmic reticulum-targeting activatable nanophotosensitizers for hypoxia relief and enhanced photodynamic therapy.

本文引用的文献

1
Integration of TADF Photosensitizer as "Electron Pump" and BSA as "Electron Reservoir" for Boosting Type I Photodynamic Therapy.TADF 光敏剂作为“电子泵”和 BSA 作为“电子库”的整合,用于增强型 I 型光动力疗法。
J Am Chem Soc. 2023 Apr 12;145(14):8130-8140. doi: 10.1021/jacs.3c01042. Epub 2023 Mar 31.
2
Overcoming the Oxygen Dilemma in Photoredox Catalysis: Near-Infrared (NIR) Light-Triggered Peroxynitrite Generation for Antibacterial Applications.克服光氧化还原催化中的氧气困境:近红外(NIR)光触发过氧亚硝酸盐生成用于抗菌应用。
Angew Chem Int Ed Engl. 2023 May 8;62(20):e202219153. doi: 10.1002/anie.202219153. Epub 2023 Apr 12.
3
用于缓解缺氧和增强光动力治疗的内质网靶向可激活纳米光敏剂。
Chem Sci. 2025 May 6. doi: 10.1039/d5sc00534e.
4
pH-Responsive AIE Photosensitizers for Enhanced Antibacterial Therapy.用于增强抗菌治疗的pH响应型聚集诱导发光光敏剂
Angew Chem Int Ed Engl. 2025 Jul;64(27):e202506505. doi: 10.1002/anie.202506505. Epub 2025 May 8.
5
Nanoparticles for Photodynamic Therapy of Breast Cancer: A Review of Recent Studies.用于乳腺癌光动力治疗的纳米颗粒:近期研究综述
Molecules. 2025 Mar 31;30(7):1571. doi: 10.3390/molecules30071571.
6
PhotoChem Interplays: Lighting the Way for Drug Delivery and Diagnosis.光化学相互作用:为药物递送和诊断照亮道路。
Adv Drug Deliv Rev. 2025 Apr;219:115549. doi: 10.1016/j.addr.2025.115549. Epub 2025 Feb 20.
7
Nanoparticle-Mediated Cuproptosis and Photodynamic Synergistic Strategy: A Novel Horizon for Cancer Therapy.纳米颗粒介导的铜死亡与光动力协同策略:癌症治疗的新视野
Cancer Med. 2025 Feb;14(3):e70599. doi: 10.1002/cam4.70599.
8
Nanocatalytic medicine enabled next-generation therapeutics for bacterial infections.纳米催化医学助力细菌感染的下一代治疗方法。
Mater Today Bio. 2024 Sep 16;29:101255. doi: 10.1016/j.mtbio.2024.101255. eCollection 2024 Dec.
Supramolecular Photosensitizer Enables Oxygen-Independent Generation of Hydroxyl Radicals for Photodynamic Therapy.
超分子光敏剂实现用于光动力疗法的不依赖氧气的羟基自由基生成。
J Am Chem Soc. 2023 Feb 13. doi: 10.1021/jacs.2c11868.
4
From Low to No O-Dependent Hypoxia Photodynamic Therapy (hPDT): A New Perspective.从低氧到无 O-依赖缺氧光动力疗法(hPDT):新视角。
Acc Chem Res. 2022 Nov 15;55(22):3253-3264. doi: 10.1021/acs.accounts.2c00531. Epub 2022 Nov 2.
5
Lactose azocalixarene drug delivery system for the treatment of multidrug-resistant pseudomonas aeruginosa infected diabetic ulcer.乳糖偶氮杯芳烃药物递送系统治疗多重耐药铜绿假单胞菌感染的糖尿病溃疡。
Nat Commun. 2022 Oct 21;13(1):6279. doi: 10.1038/s41467-022-33920-7.
6
Supramolecular photodynamic agents for simultaneous oxidation of NADH and generation of superoxide radical.用于同时氧化 NADH 和生成超氧自由基的超分子光动力剂。
Nat Commun. 2022 Oct 19;13(1):6179. doi: 10.1038/s41467-022-33924-3.
7
Potentiating hypoxic microenvironment for antibiotic activation by photodynamic therapy to combat bacterial biofilm infections.通过光动力疗法增强缺氧微环境以激活抗生素,从而对抗细菌生物膜感染。
Nat Commun. 2022 Jul 5;13(1):3875. doi: 10.1038/s41467-022-31479-x.
8
Photocatalytic Superoxide Radical Generator that Induces Pyroptosis in Cancer Cells.光催化超氧自由基发生器诱导癌细胞发生细胞焦亡。
J Am Chem Soc. 2022 Jun 29;144(25):11326-11337. doi: 10.1021/jacs.2c03256. Epub 2022 Jun 16.
9
Cationization-Enhanced Type I and Type II ROS Generation for Photodynamic Treatment of Drug-Resistant Bacteria.阳离子化增强I型和II型活性氧生成用于耐药细菌的光动力治疗
ACS Nano. 2022 Jun 28;16(6):9130-9141. doi: 10.1021/acsnano.2c01206. Epub 2022 May 18.
10
Emerging Strategies in Enhancing Singlet Oxygen Generation of Nano-Photosensitizers Toward Advanced Phototherapy.增强纳米光敏剂单线态氧生成用于先进光疗的新兴策略
Nanomicro Lett. 2022 May 5;14(1):123. doi: 10.1007/s40820-022-00856-y.